Penserra Capital Management LLC Magenta Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.43 - $8.33 $5,914 - $11,120	-1,335 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $60 - $98	10 Added 0.75%	1,335 $9,000
Q2 2021 Aug 12, 2021	BUY	$9.76 - $14.15 $2,244 - $3,254	230 Added 21.0%	1,325 $12,000
Q1 2021 May 13, 2021	SELL	$7.66 - $13.38 $114 - $200	-15 Reduced 1.35%	1,095 $12,000
Q4 2020 Feb 12, 2021	BUY	$6.1 - $7.94 $4,257 - $5,542	698 Added 169.42%	1,110 $8,000
Q3 2020 Nov 13, 2020	BUY	$6.52 - $8.94 $2,686 - $3,683	412 New	412 $2,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.